Proactive Investors - Run By Investors For Investors

OptiBiotix secures exclusive manufacturing agreement for CE marked SlimBiome

OptiBiotix Health plc (LON:OPTI) chief executive Stephen O'Hara tells Proactive London's Andrew Scott they've agreed a production, packaging and supply agreement for its CE Marked weight management product.

Italy’s Nutrilinea will formulate and distribute SlimBiome Medical, which also has medical device status, in boxes of 30 single sachet doses for sale across its network and the UK firm’s growing list of partners.

 
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »
View full OPTI profile View Profile

OptiBiotix Health PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use